Презентация на тему: PHARMACOTHERAPEUTICS IN

PHARMACOTHERAPEUTICS IN
PHARMACOTHERAPEUTICS IN
OXYTOCI C S IN OBSTETRICS
OXYTOCIN
OXYTOCIN
I NDIC A TIONS
I NDIC A TIONS
PHARMACOTHERAPEUTICS IN
A DVERSE EFFECTS
ERGOT DERIVATIVES
ERGOT DERIVATIVES
PHARMACOTHERAPEUTICS IN
ERGOT DERIVATIVES
ERGOT DERIVATIVES
PROSTAGLANDINS
PROSTAGLANDINS
PROSTAGLANDINS
PROSTAGLANDINS
ANTI-HYPERTENSIVE THERAPY
CALCIUM CHANNEL BLOCKERS
CALCIUM CHANNEL BLOCKERS
ANTICONVULSANTS
ANALGESIA AND ANAESTHESIA IN OBSTETRICS
EPIDURAL ANAESTHESIA
GENERAL ANAESTHESIA
Mechanism of teratogenicity
PHARMACOTHERAPEUTICS IN
P LACENTAL TRANSFER OF DRUGS
MATERNAL DRUG INTAKE AND BREASTFEEDING
D RUGS IDENTIFIED AS HAVING EFFECT ON LACTATION AND THE NEONATE
THANK YOU……..
1/31
Средняя оценка: 5.0/5 (всего оценок: 47)
Код скопирован в буфер обмена
Скачать (9544 Кб)
1

Первый слайд презентации: PHARMACOTHERAPEUTICS IN

OBSTETRICS Efforts by Vanshul Rana Group 173B LA-1 International Medical Faculty

Изображение слайда
2

Слайд 2

GUIDELINES If the benefit outweighs the potential risks, only then can the particular drugs be used with prior counselling. Only, well tested and reputed drugs are to be prescribed and that too using the minimum therapeutic dosage for the shortest possible duration.

Изображение слайда
3

Слайд 3: OXYTOCI C S IN OBSTETRICS

OX Y T OCIN ERGOT DERIVATIVES PROSTAGLANDINS

Изображение слайда
4

Слайд 4: OXYTOCIN

It is synthesised in the supra-optic and para ventricular nuclei of the hypothalamus. a half life of 3-4 minutes and duration of action of approximately 20 minutes Mode of action receptor and voltage mediated calcium channels amniotic and prostaglandin decidual production

Изображение слайда
5

Слайд 5: OXYTOCIN

Preparations used Synthetic oxytocin Syntometrine Desamino oxytocin Oxytocin nasal solution Effectiveness In later months of pregnancy and during labour

Изображение слайда
6

Слайд 6: I NDIC A TIONS

THERAPEUTIC: Pregnancy: Early: to accelerate abortion. To stop bleeding following evacuation of the uterus. Used as an adjunct of abortion along with other abortifacient agents. Late: To induce labour. To facilitate cervical ripening for effective induction. Augmentation of labour. Uterine intertia.

Изображение слайда
7

Слайд 7: I NDIC A TIONS

Labour: In active management of third stage of labour. Following expulsion of placenta. Pueperium: To minimize the blood loss and to control the PPH. DIAGNOSTIC: Contraction stress test Oxytocin Stimulation test

Изображение слайда
8

Слайд 8

Contraindications of oxytocin: Pregnancy: Grand multipara. Contracted pelvis. History of caesarean or hysterotomy. Malpresentation. Labour: All the contraindications in pregnancy. Obstructed labour. Inco-ordinate uterine action. Fetal distress. Any time: Hypovolemic state. Cardiac disease.

Изображение слайда
9

Слайд 9: A DVERSE EFFECTS

MATERNAL Uterine hyperstimulation Uterine rupture Water intoxication Hypotension Ant i -d i u r e s is FETAL Fetal distress, fetal hypoxia and fetal death

Изображение слайда
10

Слайд 10: ERGOT DERIVATIVES

INDICATIONS: Prophylactic: Suspected plural pregnancy. Organic cardiac diseases. Severe pre-eclampsia and eclampsia Rh- negative mother. Therapeutic: Heart disease or severe hypertensive disorders

Изображение слайда
11

Слайд 11: ERGOT DERIVATIVES

Preparations Ampoules tablet Ergometrine[ergon ovine] 0.25 mg or 0.5 mg 0.5 mg Methergin[methyl- ergonovine] S y ntomet r in e [Sand oz] 0.2 mg 0.5 mg ergomet r i n e + 5 units of syntometrine 0.5-1 mg

Изображение слайда
12

Слайд 12

Onset of action Routes Ergometrine Methergin IV IM Oral 45-60sec 6 - 7mt 10 mt 5.min 7 min 10 min

Изображение слайда
13

Слайд 13: ERGOT DERIVATIVES

Hazards: Common side effects are nausea and vomiting. Precipitate rise of blood pressure, myocardial infarction, stroke and bronchospasm because of vasoconstrictive effect. Prolonged use may result in gangrene formation of the toes. Prolonged use in puerperium may interfere with lactation.

Изображение слайда
14

Слайд 14: ERGOT DERIVATIVES

Cautions: Ergometrine should not be used during pregnancy, first stage of labour, second stage of labour, second stage prior to crowning of the head and in breech delivery prior to crowning

Изображение слайда
15

Слайд 15: PROSTAGLANDINS

Source arachidonic acid Mechanism of action PGF 2α promotes myometrial contractility PGE 2 helps cervical maturation

Изображение слайда
16

Слайд 16: PROSTAGLANDINS

Use in obstetrics Induction of abortion. Termination of molar pregnancy. Induction of labour. Cervical ripening prior to the induction of abortion or labour. Acceleration of labour. Management of atonic PPH. Medical management of tubal ectopic pregnancy. Contraindications: Hypersensitivity to the compound. Uterine scar. Preparations Tablet. Vaginal suppository

Изображение слайда
17

Слайд 17: PROSTAGLANDINS

Advantages: It has got a powerful oxytocic effect, irrespective of period of pregnancy. As such it can be used independently specially in the induction of abortion with success. In later months it can be used for acceleration of labour. It has got no anti diuretic effect.

Изображение слайда
18

Слайд 18: PROSTAGLANDINS

Drawbacks: It is costly. Unpleasant side effects on systemic use are nausea, vomiting, diarrhoea, pyrexia or bronchospasm. When used as abortifacient, extensive lacerations may occur. Tachysystole.

Изображение слайда
19

Слайд 19: ANTI-HYPERTENSIVE THERAPY

1. Symp athom imetic s 1. adrenergic Recep t or blocking agent 1. vasodilat ors 1. calcium channe l blocke rs 1. ACEI Inh i bit ors Methyldo pa Labetalol Hydralazine Nifedipine Captopril Propanalol Prazocin nicardia lisinopril Reserpin e Sodium nitrop r u s s i de

Изображение слайда
20

Слайд 20: CALCIUM CHANNEL BLOCKERS

Nifedipine Nicardipine Mechanism of action: Nifedipine blocks the entry of calcium inside the cell. Compared to β- mimetics, effects are less. It is equally effective to MgSO 4. Dose: Oral 10-20 mg every 6-8 hours.

Изображение слайда
21

Слайд 21: CALCIUM CHANNEL BLOCKERS

Side effects: Maternal Hypotension Headache Flushing Nausea

Изображение слайда
22

Слайд 22: ANTICONVULSANTS

1. MAGNESIUM SULPHATE - IM – loading dose: 4 gm IV [20% solution] over 3-5 min. to follow 10 gm deep IM, 5gm in each buttocks. Maintenance dose : 5gm deep IM on alternate buttocks every 4 hrs. 2. DIAZEPAM - 20-40 mg IV 3. PHENYTOIN - 10 mg/ kg IV at the rate not more than 50 mg/ min followed 2 hrs later by 5 mg/kg. In epilepsy 300- 400 mg daily orally in divided doses.

Изображение слайда
23

Слайд 23: ANALGESIA AND ANAESTHESIA IN OBSTETRICS

1. SEDATIVES AND ANALGESICS OPIOID ANALGESICS: PETHIDINE Mechanism of action: Inhibits ascending pain pathways in CNS, increase pain threshold and alters pain perception. Indications: Moderate to severe pain in labour, postoperative pain, abruption placentae, pulmonary edema. Dose: Injectable preparations contains 50mg/ml can be administered SC, IM,IV. Its dose is 50-100 mg IM combined with promethazine.

Изображение слайда
24

Слайд 24: EPIDURAL ANAESTHESIA

Epidural block consists of a local anesthetic bupivacaine (Marcaine) along with an analgesic morphine (Duramorph) or fentanyl (Sublimaze) injected into the epidural space at the level of the fourth of fifth vertebrae. Adverse effects Maternal hypotension. Fetal bradycardia. Inability to feel the urge to void. Loss of the bearing down reflex.

Изображение слайда
25

Слайд 25: GENERAL ANAESTHESIA

100% oxygen is administered by tight mask fit for more than 3 minutes. Induction of anaesthesia is done with the injection of thiopentone sodium 200- 250 mg as a 2.5 % solution IV.,followed by refrigerated suxamethonium 100 mg. the patient is intubated with cuffed ET tube. Anaesthesia is maintained with 50% NO 2, 50% oxygen and a trace of halothane. Relaxation is maintained with non- depolarizing muscle relaxant [ vecuronium 4 mg or atracurium 25 mg].

Изображение слайда
26

Слайд 26: Mechanism of teratogenicity

FETAL HAZARDS ON MATERNAL MEDICATION DURING PREGNANCY Mechanism of teratogenicity Folic acid deficiency. Epoxides or arena oxides Environmental and genes abnormalities. Maternal disease and drugs Homebox genes

Изображение слайда
27

Слайд 27

Maternal-fetal drug transfer and the hazards: before D 31: Teratogen produces an all or none effect. D31-d71: It is the critical period for organ formation. After D 71: The development of other organs continues.

Изображение слайда
28

Слайд 28: P LACENTAL TRANSFER OF DRUGS

The factors responsible for transfer are: Molecular weight [molecular wght more than 1000 Da do not cross the placenta]. Concentration of free drug. Lipid solubility. Utero-placental blood flow. Placental solubility.

Изображение слайда
29

Слайд 29: MATERNAL DRUG INTAKE AND BREASTFEEDING

Transfer of drugs through breast milk depends on following factors: Chemical properties Molecular weight Degree of protein binding Ionic dissociation Lipid solubility Tissue pH. Drug concentration. Exposure time.

Изображение слайда
30

Слайд 30: D RUGS IDENTIFIED AS HAVING EFFECT ON LACTATION AND THE NEONATE

Bromide: Rash. Drowsiness, and poor feeding. Iodides: Neonatal hypothyroidism Chloramohenicol: Bone marrow toxicity Oral pill: Suppression of lactation. Bromocriptine: Suppression of lactation. Ergot: Suppression of lactation. Metronidazole: Anorexia, blood dyscrasias, irritability, weakness, neurotoxic disorders. Anticoagulants: Haemorrhagic tendency. Isoniazid: Anti-DNA activity and hepatotoxicity. Anti-thyroid drugs and radioactive iodine: Hypothyroidism and goitre, agranulocytosis. Diazepam, opiates, phenobarbitone: Sedation effect with poor sucking reflex.

Изображение слайда
31

Последний слайд презентации: PHARMACOTHERAPEUTICS IN: THANK YOU……

Изображение слайда